Los Angeles Times Editorial Board Cites Public Citizen on the Global Vaccine

By The Editorial Board

“The U.S. can go further by using its clout and resources to jump-start production in developing nations and to pressure vaccine makers and research institutions to share their technology. Public Citizen, a nonprofit consumer advocacy organization, estimates that if the U.S. uses all its legal authority to spur vaccine production, it could help produce billions more doses, save countless lives and end the pandemic years earlier.”

Read the full story here.